BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shahid I, Alzahrani AR, Al-Ghamdi SS, Alanazi IM, Rehman S, Hassan S. Hepatitis C Diagnosis: Simplified Solutions, Predictive Barriers, and Future Promises. Diagnostics (Basel) 2021;11:1253. [PMID: 34359335 DOI: 10.3390/diagnostics11071253] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Duah E, Mathebula EM, Mashamba-Thompson T. Quality Assurance for Hepatitis C Virus Point-of-Care Diagnostics in Sub-Saharan Africa. Diagnostics (Basel) 2023;13. [PMID: 36832172 DOI: 10.3390/diagnostics13040684] [Reference Citation Analysis]
2 Ansu-Mensah M, Kuupiel D, Asiamah EA, Ginindza TG. Facilitators and barriers to in vitro diagnostics implementation in resource-limited settings: A scoping review. Afr J Prim Health Care Fam Med 2023;15:e1-9. [PMID: 36861922 DOI: 10.4102/phcfm.v15i1.3777] [Reference Citation Analysis]
3 Roy A, Roy M, Gacem A, Datta S, Zeyaullah M, Muzammil K, Farghaly TA, Abdellattif MH, Yadav KK, Simal-Gandara J. Role of bioactive compounds in the treatment of hepatitis: A review. Front Pharmacol 2022;13:1051751. [PMID: 36618936 DOI: 10.3389/fphar.2022.1051751] [Reference Citation Analysis]
4 Häkkinen M, Tourunen J, Pitkänen T, Simojoki K, Vuoti S. Integrated care model and point of care diagnostics facilitate Hepatitis C treatment among patients receiving opioid agonist therapy: a retrospective review of medical records. Subst Abuse Treat Prev Policy 2022;17:44. [DOI: 10.1186/s13011-022-00473-3] [Reference Citation Analysis]
5 Yousafzai MT, Alavi M, Valerio H, Hajarizadeh B, Grebely J, Dore GJ. Timely Hepatitis C RNA Testing and Treatment in the Era of Direct-Acting Antiviral Therapy among People with Hepatitis C in New South Wales, Australia. Viruses 2022;14:1496. [PMID: 35891474 DOI: 10.3390/v14071496] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Walters F, Burwell G, Mitchell JJ, Ali MM, Daghigh Ahmadi E, Mostert AB, Jenkins CA, Rozhko S, Kazakova O, Guy OJ. A Rapid Graphene Sensor Platform for the Detection of Viral Proteins in Low Volume Samples. Advanced NanoBiomed Research. [DOI: 10.1002/anbr.202100140] [Reference Citation Analysis]
7 Sintusek P, Thanapirom K, Komolmit P, Poovorawan Y. Eliminating viral hepatitis in children after liver transplants: How to reach the goal by 2030. World J Gastroenterol 2022; 28(3): 290-309 [DOI: 10.3748/wjg.v28.i3.290] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Carty PG, McCarthy M, O'Neill SM, De Gascun CF, Harrington P, O'Neill M, Smith SM, Teljeur C, Ryan M. Laboratory-based testing for hepatitis C infection using dried blood spot samples: A systematic review and meta-analysis of diagnostic accuracy. Rev Med Virol 2021;:e2320. [PMID: 34957630 DOI: 10.1002/rmv.2320] [Reference Citation Analysis]
9 Jee Y. Inclusion of hepatitis C virus testing in National Health Screening to accelerate HCV elimination in South Korea. Glob Health Med 2021;3:288-92. [PMID: 34782871 DOI: 10.35772/ghm.2021.01057] [Reference Citation Analysis]